134 related articles for article (PubMed ID: 3883734)
1. Clinical and hemodynamic effects of the new dilator drug molsidomine.
Malcolm AD
Am Heart J; 1985 Mar; 109(3 Pt 2):674-7. PubMed ID: 3883734
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol.
De Backer GG; Derese A
Am Heart J; 1985 Mar; 109(3 Pt 2):678-81. PubMed ID: 3883735
[TBL] [Abstract][Full Text] [Related]
3. Molsidomine in the treatment of patients with angina pectoris.
Majid PA; DeFeyter PJ; Van der Wall EE; Wardeh R; Roos JP
N Engl J Med; 1980 Jan; 302(1):1-6. PubMed ID: 6985697
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure.
Rudolph W; Dirschinger J
Am Heart J; 1985 Mar; 109(3 Pt 2):670-4. PubMed ID: 3883733
[TBL] [Abstract][Full Text] [Related]
5. [Duration of the antianginal effect of oral molsidomine in exertion angina. Double-blind, crossed and randomized study].
Bordes P; Gimeno JV; Olagüe J; Ferrer J; Hernández M; Algarra F
Rev Esp Cardiol; 1986; 39(2):138-42. PubMed ID: 3523649
[No Abstract] [Full Text] [Related]
6. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
[TBL] [Abstract][Full Text] [Related]
7. [Anti-ischemic effect of 8 mg molsidomin in retard form].
Blasini R; Brügmann U; Rudolph W
Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and coronary effects of molsidomine at basal state, during atrial pacing, and during cold pressor test in patients with stable angina pectoris.
Juliard JM; Neukirch F; Zygelman M; Merillon JP; Michel PL; Pansard Y; Dahan M; Gourgon R
Am Heart J; 1985 Mar; 109(3 Pt 2):662-6. PubMed ID: 3838404
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
[TBL] [Abstract][Full Text] [Related]
10. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
Fach WA; Becker HJ
Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
[TBL] [Abstract][Full Text] [Related]
11. The influence of molsidomine on the hemodynamics of patients with chronic heart failure at rest and during exercise.
Larbig DT; Milstrey HR; Nasse H; Kahle T
Am Heart J; 1985 Mar; 109(3 Pt 2):688-90. PubMed ID: 3883738
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of molsidomine on exercise tolerance in patients with exertional angina pectoris.
Kinoshita M; Sawamura M; Motomura M; Takayama Y; Kawaguchi Y; Kawakita S
Jpn Circ J; 1983 Dec; 47(12):1398-405. PubMed ID: 6689183
[TBL] [Abstract][Full Text] [Related]
13. [Molsidomine in the long-term treatment of angina pectoris].
Blasini R; Brügmann U; Mannes A; Rudolph W
Herz; 1982 Oct; 7(5):307-16. PubMed ID: 6818116
[No Abstract] [Full Text] [Related]
14. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
Witchitz S; Kolsky H; Moisson P; Valette H
Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971
[TBL] [Abstract][Full Text] [Related]
15. [Molsidomine: evaluation of a single dose using the exercise test].
Ruano J; Zueco J; Colman T; López C; Pajarón A
Rev Esp Cardiol; 1985; 38(2):93-7. PubMed ID: 3890039
[No Abstract] [Full Text] [Related]
16. Penbutolol and molsidomine synergism in angina pectoris. A double blind ergometric trial.
Balestrini AE; Menzio AC; Cabral R; Feldman R; Mercogliano C; Flichtentrei D; Albera HP; Vazquez A
Eur J Clin Pharmacol; 1984; 27(1):1-5. PubMed ID: 6386486
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical and hemodynamic results of molsidomine treatment in patients with refractory heart failure.
Acar J; Kulas A; Escudier B
Am Heart J; 1985 Mar; 109(3 Pt 2):685-7. PubMed ID: 3883737
[TBL] [Abstract][Full Text] [Related]
18. Molsidomine--an effective antianginal drug. Results of an acute randomized stress-testing study.
Mindlin de Aptecar FR; Vazquez A; Aptecar M
Cardiology; 1985; 72(4):185-92. PubMed ID: 3902224
[TBL] [Abstract][Full Text] [Related]
19. [Synergic action of molsidomine and atenolol in patients with exertion angina. Cycloergometric study].
Gimeno JV; Olagüe J; Bueno FJ; Tellols R; Martín G; Ferrer J
Med Clin (Barc); 1984 Nov; 83(15):624-8. PubMed ID: 6549203
[No Abstract] [Full Text] [Related]
20. Exercise tolerance in coronary patients: randomized trial of two-week treatment with molsidomine versus placebo.
Messin R
Am Heart J; 1985 Mar; 109(3 Pt 2):667-9. PubMed ID: 3883732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
